Skip to content

Clinical trials

Phase 3 Heart Diseases trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Phase 3 Country / region: Czechia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20071
20081
20092
20101
20111
20131
20181
20191
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
GlaxoSmithKline2
AstraZeneca1
Bayer1
Biosense Webster, Inc.1
CSL Behring1
Eidos Therapeutics, a BridgeBio company1
Forest Laboratories1
Idorsia Pharmaceuticals Ltd.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases13
Cardiovascular Diseases6
Acute Coronary Syndrome4
Atherosclerosis4
Stroke4
Atrial Fibrillation3
Coronary Artery Disease3
Peripheral Arterial Disease3
Arrhythmias, Cardiac2
Coronary Disease2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.